| Revenue growth | Full year revenue reached ₹67,137 million with pharma growing 40%. |
|---|---|
| Margins | EBITDA margins maintained at 25% despite pricing pressures. |
| Order book | Agchem order book remains robust at approximately $1.2 billion. |
| Demand visibility | Muted near-term global demand; expected recovery in upcoming Kharif season. |
| Management confidence | Confident but realistic about navigating the global agrochemical downcycle. |
Growth
Revenue grew to ₹67,137 million with steady 25% EBITDA margins. Growth was volume-led in Pharma (40%) but offset by global agrochemical headwinds.
Outlook
Guided for positive revenue growth in FY27. Projecting $100M revenue from electronic chemicals in 4-5 years.
Risks
High concentration in a single molecule; global agrochemical oversupply; rising R&D and launch costs for new entities.
Earnings Call filed with BSE, NSE: PIIND. Summary written with AI assistance from the document.
PI Industries Ltd: key numbers
- Share price
- ₹2,400.00
- Market cap
- ₹36,412 Cr
- Revenue (annual)
- ₹6,714 Cr
- Net profit (annual)
- ₹1,321 Cr
- P/E (TTM)
- 31.3×Sector 37.5×
- Promoter holding
- 46.09%+0.00% QoQ
- FII holding
- 14.83%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from PI Industries Ltd
All →PI Industries Other Announcement
Bhavina J Dholariya, an immediate relative of an insider, sold equity shares of PI Industries Ltd. The market sale was valued at ₹0.12 Crore.
- Value
- ₹0.12 Cr
PI Industries Product Launch
PI Industries received registration for its indigenously developed insecticide, 'Pioxaniliprole' (branded 'Pioxazon'), marking a key milestone in its agricultural innovation journey.
PI Industries Earnings Call Transcript: Key Takeaways
PI Industries Q1 FY27 results show resilience amidst global agrochemical headwinds, maintaining healthy EBITDA margins at 22% despite revenue softness. Management remains optimistic about a second-half recovery driven by domestic monsoon improvement and new product scale-ups.
- Call
- Guides 5% growth
PI Industries Investor Presentation: Key Takeaways
PI Industries Q1 FY27 consolidated revenue fell 10% to ₹17,023 Mn, with EBITDA down 29% and PAT down 39% due to global agrochemical headwinds and cyclical disruptions.
PI Industries Q1 FY27 Results: Net Profit ₹244.2 Cr, Down 39.0% YoY
PI Industries Ltd reported revenue from operations of ₹1,702 Cr (-10.4% YoY) and net profit of ₹244.2 Cr (-39.0% YoY) for Q1 FY27.
- Key figure
- Net profit ₹244.2 Cr · -39.0% YoY
PI Industries Earnings Call: Key Takeaways
PI Industries delivered FY26 revenue of ₹67,137M with 25% EBITDA margins. Management transitioned to an innovator-led model with the launch of its first homegrown NCE, Pioxaniliprole.